AnalystsMazahir AlimohamedMazahir Alimohamed's Stock Forecasts
AnalystsMazahir Alimohamed
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4876 out of 5549 analysts
Average Return
-22.59%
Win Rate
14%1 out of 7
Risk vs Reward
Poor
Good
Mazahir Alimohamed's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Irulya Therapeutics IncIRLA | +43.73% | $22.00 | $31.62 | 2026-07-29 - 2026-10-29 | Buy |
Mazahir Alimohamed Analyst Color
Get additional color on Mazahir Alimohamed's coverage of popular stocks
Mazahir Alimohamed's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $16.00 | +492.59% | Maintains | 10 days ago |
Tyra Biosciences IncTYRA | 1 | Buy | $40.00 | +86.22% | Reiterates | a month ago |
Connect Biopharma Holdings LtdCNTB | 2 | Buy | $5.00 | +498.80% | Maintains | a month ago |
Irulya Therapeutics IncIRLA | 1 | Buy | $82.00 | +159.33% | Initiates Coverage On | 3 months ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $51.00 | +31.07% | Initiates Coverage On | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.